PRODUCT

°í°´¸¸Á·À» À§ÇØ Áö¼ÓÀûÀ¸·Î °í¹ÎÇϰí Çõ½ÅÇÏ¿© ÃÖ°íÀÇ Ç°ÁúÀ» Á¦°øÇÕ´Ï´Ù.

R&D reagents

Product > R&D reagents
Donepezil HCl, 98% (HPLC)
CAS No 71750-1g
Á¦Ç°¹øÈ£ AK Sci.(USA)
Á¦Á¶»ç ¼öÀÔ»ê
Àç°í 1 EA
±Ý¾× 149,000¿ø
Æ÷Àå´ÜÀ§



2-(1-Benzyl-4-piperidylmethyl)-5,6-dimethoxy-1-indanone hydrochloride
Aricept





¡Ø È­Çиí : Donepezil HCl, 98% (HPLC)

 

¡Ø µî±Þ : APIs and Bioactives > AChR Agonists

 

¡Ø ÆÇ¸Å Æ÷Àå´ÜÀ§ : 1g , 5g

 

¡Ø È­ÇÐ½Ä : C24H30ClNO3

 

¡Ø CAS # : [120011-70-3]

 

 

IDENTITY
CAS Registry #: [120011-70-3]
MDL Number: MFCD00881312
MF: C24H30ClNO3
MW: 415.95
SPECIFICATIONS & PROPERTIES
Purity: 98% (HPLC)
Available Spectra:

 

LCMS, HPLC

Physical Form: White to off-white powder
Melting Point: 223-227¡ÆC
Long-Term Storage:

 

Store at room temperature

Shipping: Not Regulated for Shipping

BIOLOGICAL INFO
Solubility: DMSO: 1mg/mL; H2O: 31mg/mL; EtOH: 2mg/mL
Application(s): AChE inhibitor; bAChE; hAChE
Form: HCl salt

REVIEW

A centrally acting reversible acetylcholinesterase inhibitor. The main therapeutic use is in the palliative treatment of mild to moderate Alzheimers disease.

REFERENCES
[1] Myhrer T, Enger S, Aas P (2010). Behavioral side effects in rats treated with acetylcholinesterase inhibitors suggested used as prophylactics against nerve agents. Pharmacol Biochem Behav. 95(3):338-43. PMID 20184916.

Risk Description(s)
R36/37/38: Irritating to eyes, respiratory system and skin

Safety Description(s)
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36: Wear suitable protective clothing.